Disrupted mitochondrial homeostasis coupled with mitotic arrest generates antineoplastic oxidative stress.
Disrupted mitochondrial homeostasis coupled with mitotic arrest generates antineoplastic oxidative stress.
复制标题
线粒体稳态破坏加上有丝分裂停滞会产生抗肿瘤氧化应激
DOI:
10.1038/s41388-021-02105-9
复制
发表时间:
2022-01
期刊:
影响因子:
8
通讯作者:
Shao C
中科院分区:
文献类型:
--
作者:
Hao X;Bu W;Lv G;Xu L;Hou D;Wang J;Liu X;Yang T;Zhang X;Liu Q;Gong Y;Shao C
Reactive oxygen species (ROS) serve as critical signals in various cellular processes. Excessive ROS cause cell death or senescence and mediates the therapeutic effect of many cancer drugs. Recent studies showed that ROS increasingly accumulate during G2/M arrest, the underlying mechanism, however, has not been fully elucidated. Here, we show that in cancer cells treated with anticancer agent TH287 or paclitaxel that causes M arrest, mitochondria accumulate robustly and produce excessive mitochondrial superoxide, which causes oxidative DNA damage and undermines cell survival and proliferation. While mitochondrial mass is greatly increased in cells arrested at M phase, the mitochondrial function is compromised, as reflected by reduced mitochondrial membrane potential, increased SUMOylation and acetylation of mitochondrial proteins, as well as an increased metabolic reliance on glycolysis. CHK1 functional disruption decelerates cell cycle, spares the M arrest and attenuates mitochondrial oxidative stress. Induction of mitophagy and blockade of mitochondrial biogenesis, measures that reduce mitochondrial accumulation, also decelerate cell cycle and abrogate M arrest-coupled mitochondrial oxidative stress. These results suggest that cell cycle progression and mitochondrial homeostasis are interdependent and coordinated, and that impairment of mitochondrial homeostasis and the associated redox signaling may mediate the antineoplastic effect of the M arrest-inducing chemotherapeutics. Our findings provide insights into the fate of cells arrested at M phase and have implications in cancer therapy.
登录
查看更多内容
影响因子:
3.7
作者:
Fu X;Wan S;Lyu YL;Liu LF;Qi H
通讯作者:
Qi H
影响因子:
24.5
作者:
Manic G;Signore M;Sistigu A;Russo G;Corradi F;Siteni S;Musella M;Vitale S;De Angelis ML;Pallocca M;Amoreo CA;Sperati F;Di Franco S;Barresi S;Policicchio E;De Luca G;De Nicola F;Mottolese M;Zeuner A;Fanciulli M;Stassi G;Maugeri-Saccà M;Baiocchi M;Tartaglia M;Vitale I;De Maria R
通讯作者:
De Maria R
DOI:
10.15252/embj.201592862
发表时间:
2016-04-01
期刊:
The EMBO journal
影响因子:
--
作者:
Correia-Melo C;Marques FD;Anderson R;Hewitt G;Hewitt R;Cole J;Carroll BM;Miwa S;Birch J;Merz A;Rushton MD;Charles M;Jurk D;Tait SW;Czapiewski R;Greaves L;Nelson G;Bohlooly-Y M;Rodriguez-Cuenca S;Vidal-Puig A;Mann D;Saretzki G;Quarato G;Green DR;Adams PD;von Zglinicki T;Korolchuk VI;Passos JF
通讯作者:
Passos JF
DOI:
10.1084/jem.20081297
发表时间:
2008-09-29
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Chen C;Liu Y;Liu R;Ikenoue T;Guan KL;Liu Y;Zheng P
通讯作者:
Zheng P
影响因子:
5.3
作者:
Havens, Courtney G.;Ho, Alan;Dowdy, Steven F.
通讯作者:
Dowdy, Steven F.